References
- Zou L, Wang L, Gong X, et al. The association between three promoter polymorphisms of IL-10 and inflammatory bowel diseases (IBD): a meta-analysis. Autoimmunity. 2014;47(1):27–39.
- Yuan YY, Xie KX, Wang SL, et al. Inflammatory caspase-related pyroptosis: mechanism, regulation and therapeutic potential for inflammatory bowel disease. Gastroenterol Rep. 2018;6(3):167–176.
- Burisch J, Munkholm P. Inflammatory bowel disease epidemiology. Curr Opin Gastroenterol. 2013;29(4):357–362.
- Keller DS, Windsor A, Cohen R, et al. Colorectal cancer in inflammatory bowel disease: review of the evidence. Tech Coloproctol. 2019;23(1):3–13.
- Chen X, Liu G, Yuan Y, et al. NEK7 interacts with NLRP3 to modulate the pyroptosis in inflammatory bowel disease via NF-κB signaling. Cell Death Dis. 2019;10(12):906.
- Xiong Y, Lou Y, Su H, et al. Cholecalciterol cholesterol emulsion ameliorates experimental colitis via down-regulating the pyroptosis signaling pathway. Exp Mol Pathol. 2016;100(3):386–392.
- Chao KL, Kulakova L, Herzberg O. Gene polymorphism linked to increased asthma and IBD risk alters gasdermin-B structure, a sulfatide and phosphoinositide binding protein. Proc Natl Acad Sci. 2017;114(7):e1128–e1137.
- Melgar S, Shanahan F. Inflammatory bowel disease—from mechanisms to treatment strategies. Autoimmunity. 2010;43(7):463–477.
- James JP, Riis LB, Malham M, et al. MicroRNA biomarkers in IBD – differential diagnosis and prediction of colitis-associated cancer. Int J Mol Sci. 2020;21: 7893.
- Wu F, Zhang S, Dassopoulos T, et al. Identification of microRNAs associated with ileal and colonic Crohn’s disease. Inflamm Bowel Dis. 2010;16(10):1729–1738.
- Bartel DP. MicroRNAs: target recognition and regulatory functions. Cell. 2009;136(2):215–233.
- Liu S, Long J, Yuan B, et al. SUMO modification reverses inhibitory effects of smad nuclear interacting protein-1 in TGF-β responses. J Biol Chem. 2016;291(47):24418–24430.
- Wu J, Lu Y, Qin A, et al. Modafinil ameliorated pancreatic injury and inflammation through upregulating SNIP1. Gen Physiol Biophys. 2020;39(4):383–392.
- Shi Y, He C, Ma C, et al. Sa1820 SMAD nuclear interacting protein 1 (SNIP1) is decreased in inflammatory bowel disease and induces epithelial barrier dysfunction. Gastroenterology. 2016;150(4):S372–S373.
- Somu C, Mohan CD, Ambekar S, et al. Identification of a novel 1,2 oxazine that can induce apoptosis by targeting NF-κB in hepatocellular carcinoma cells. Biotechnol Rep. 2020;25:e00438.
- Skupsky J, Sabui S, Hwang M, et al. Biotin supplementation ameliorates murine colitis by preventing NF-κB activation. Cell Mol Gastroenterol Hepatol. 2020;9(4):557–567.
- Wong J, Garcia-Carbonell R, Zelic M, et al. RIPK1 mediates TNF-induced intestinal crypt apoptosis during chronic NF-κB activation. Cell Mol Gastroenterol Hepatol. 2020;9(2):295–312.
- Xie Y, Deng H, Wei R, et al. Overexpression of miR-335 inhibits the migration and invasion of osteosarcoma by targeting SNIP1. Int J Biol Macromol. 2019;133:137–147.
- Cong Z, Ye G, Bian Z, et al. Jagged-1 attenuates LPS-induced apoptosis and ROS in rat intestinal epithelial cells. Int J Clin Exp Pathol. 2018;11(8):3994–4003.
- Heckman KL, Pease LR. Gene splicing and mutagenesis by PCR-driven overlap extension. Nat Protoc. 2007;2(4):924–932.
- Zhang L, Wu H, Zhao M, et al. Identifying the differentially expressed microRNAs in autoimmunity: a systemic review and meta-analysis. Autoimmunity. 2020;53(3):122–136.
- Wu ZM, Luo J, Shi XD, et al. Icariin alleviates rheumatoid arthritis via regulating miR-223-3p/NLRP3 signalling axis. Autoimmunity. 2020;53(8):450–458.
- Zhang Y, Liu X, Bai X, et al. Melatonin prevents endothelial cell pyroptosis via regulation of long noncoding RNA MEG3/miR-223/NLRP3 axis. J Pineal Res. 2018;64:e12449.
- Shi Y, He C, Ma C, et al. Smad nuclear interacting protein 1 (SNIP1) inhibits intestinal inflammation through regulation of epithelial barrier function. Mucosal Immunology. 2017;11:835–845.
- Lu YY, Xu DC, Zhao YF, et al. Smad nuclear interacting protein 1 acts as a protective regulator of pressure overload-induced pathological cardiac hypertrophy. J Am Heart Assoc. 2016;5:e003943.
- Bonin CP, Baccarin RY, Nostell K, et al. Lipopolysaccharide-induced inhibition of transcription of tlr4 in vitro is reversed by dexamethasone and correlates with presence of conserved NFκB binding sites. Biochem Biophys Res Commun. 2013;432(2):256–261.
- Liu Z, Gan L, Xu Y, et al. Melatonin alleviates inflammasome-induced pyroptosis through inhibiting NF-κB/GSDMD signal in mice adipose tissue. J Pineal Res. 2017;63:e12414.
- Chen G, Ran X, Li B, et al. Sodium butyrate inhibits inflammation and maintains epithelium barrier integrity in a TNBS-induced inflammatory bowel disease mice model. EBioMedicine. 2018;30:317–325.
- Andersen V, Christensen J, Ernst A, et al. Polymorphisms in NF-κB, PXR, LXR, PPARγ and risk of inflammatory bowel disease. World J Gastroenterol. 2011;17(2):197–206.